These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 23252470)

  • 1. Goodbye warts, hello vitiligo: Candida antigen-induced depigmentation.
    Wilmer EN; Burkhart CN; Morrell DS
    Pediatr Dermatol; 2013; 30(6):e214-5. PubMed ID: 23252470
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intralesional injection of mumps or Candida skin test antigens: a novel immunotherapy for warts.
    Johnson SM; Roberson PK; Horn TD
    Arch Dermatol; 2001 Apr; 137(4):451-5. PubMed ID: 11295925
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intralesional immunotherapy of warts with mumps, Candida, and Trichophyton skin test antigens: a single-blinded, randomized, and controlled trial.
    Horn TD; Johnson SM; Helm RM; Roberson PK
    Arch Dermatol; 2005 May; 141(5):589-94. PubMed ID: 15897380
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Uveitis Following Treatment of Verruca Vulgaris with Intralesional
    Crowley NJ; Hagan JC; Dyer JA; Brundige TF
    Mo Med; 2017; 114(5):394-395. PubMed ID: 30228642
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lymphangitis occurring after intralesional Candida antigen injection for verruca vulgaris.
    Zubritsky L; Alikhan A
    Dermatol Online J; 2016 Jun; 22(6):. PubMed ID: 27617613
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phase 1 clinical trial of intralesional injection of Candida antigen for the treatment of warts.
    Kim KH; Horn TD; Pharis J; Kincannon J; Jones R; O'Bryan K; Myers J; Nakagawa M
    Arch Dermatol; 2010 Dec; 146(12):1431-3. PubMed ID: 21173332
    [No Abstract]   [Full Text] [Related]  

  • 7. Successful treatment of flat warts using intralesional Candida antigen.
    Ritter SE; Meffert J
    Arch Dermatol; 2003 Apr; 139(4):541-2. PubMed ID: 12707109
    [No Abstract]   [Full Text] [Related]  

  • 8. Candida immunotherapy of warts.
    Signore RJ
    Arch Dermatol; 2001 Sep; 137(9):1250-1. PubMed ID: 11559230
    [No Abstract]   [Full Text] [Related]  

  • 9. Intralesional Candida antigen for common warts in people with HIV.
    Wong A; Crawford RI
    J Cutan Med Surg; 2013; 17(5):313-5. PubMed ID: 24067850
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of recalcitrant verruca vulgaris with Candida antigen in patient with human immunodeficiency virus.
    Summers P; Richards-Altmon P; Halder R
    J Drugs Dermatol; 2009 Mar; 8(3):268-9. PubMed ID: 19271374
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An alarming complication of Candida albicans antigen treatment of recalcitrant warts.
    Signore RJ
    Dermatitis; 2005 Dec; 16(4):216; author reply 216-7. PubMed ID: 16536337
    [No Abstract]   [Full Text] [Related]  

  • 12. Intralesional Candida Antigen Immunotherapy for the Treatment of Recalcitrant and Multiple Warts in Children.
    Muñoz Garza FZ; Roé Crespo E; Torres Pradilla M; Aguilera Peirò P; Baltà Cruz S; Hernández Ruiz ME; Baselga Torres E
    Pediatr Dermatol; 2015; 32(6):797-801. PubMed ID: 26584692
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regression of Nevi After Candida Injection for the Treatment of Verruca Vulgaris.
    Kollmann E; Cleaver D; Cleaver L; Cleaver J
    Pediatr Dermatol; 2017 Mar; 34(2):199-200. PubMed ID: 27981626
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combined bivalent human papillomavirus vaccine and Candida antigen versus Candida antigen alone in the treatment of recalcitrant warts.
    Marei A; Nofal A; Alakad R; Abdel-Hady A
    J Cosmet Dermatol; 2020 Mar; 19(3):758-762. PubMed ID: 31328869
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Peripheral blood toll-like receptor 4 correlates response to candida immunotherapy of warts.
    Sabry HH; Hamed AM; Salem RM; Marei AM; El Sebaey RM
    Dermatol Ther; 2018 Sep; 31(5):e12691. PubMed ID: 30226014
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alternating intralesional purified protein derivative and Candida antigen versus either agent alone in the treatment of multiple common warts.
    Nofal A; Yehia E; Khater E; Bessar H
    J Am Acad Dermatol; 2020 Jul; 83(1):208-210. PubMed ID: 32006600
    [No Abstract]   [Full Text] [Related]  

  • 17. Treatment of nongenital cutaneous warts.
    Mulhem E; Pinelis S
    Am Fam Physician; 2011 Aug; 84(3):288-93. PubMed ID: 21842775
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of warts with Candida antigen injection.
    Phillips RC; Ruhl TS; Pfenninger JL; Garber MR
    Arch Dermatol; 2000 Oct; 136(10):1274-5. PubMed ID: 11030787
    [No Abstract]   [Full Text] [Related]  

  • 19. Complement component 3c and tumor necrosis factor-α systemic assessment after Candida antigen immunotherapy in cutaneous warts.
    Hammad NM; Abdelhadi AA; Fawzy MM; Marei A
    Braz J Microbiol; 2020 Dec; 51(4):1673-1681. PubMed ID: 32594377
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Topical 5-fluorouracil has no additional benefit in treating common warts with cryotherapy: a single-centre, double-blind, randomized, placebo-controlled trial.
    Luk NM; Tang WY; Tang NL; Chan SW; Wong JK; Hon KL; Lo KK
    Clin Exp Dermatol; 2006 May; 31(3):394-7. PubMed ID: 16681586
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.